Jack Khouri

50PUBLICATIONS
182CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Humoural immunology and immunochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Jul 16, 2026
Response kinetics and depth of response after idecabtagene vicleucel in relapsed/refractory multiple myeloma.

|Jul 02, 2026
Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell Leukemia.

|Jun 16, 2026
Dexamethasone for Management of Cytokine Release Syndrome Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma.

|May 27, 2026
Smoldering Multiple Myeloma: Early Intervention or Structured Surveillance? A Comprehensive Review of Evidence for and Against Early Therapy.

|May 18, 2026
Condensed vs. Standard Step-Up Dosing Schedule of Talquetamab in Relapsed/Refractory Multiple Myeloma.

|Apr 29, 2026
Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort.

Pageof 9

Frequent Collaborators

22 joint publications

Faiz Anwer

20 joint publications

James A Davis

18 joint publications

Danai Dima

17 joint publications

Surbhi Sidana